# SAM #6912710440008

VA emergency bridge award for Pluvicto and Lutathera radiopharmaceuticals

**Buyer:** VA 262 Network Contract Office 22
**Posted:** October 29, 2026
**Identifier:** 6912710440008
**NAICS:** 325412, 424210

The Department of Veterans Affairs awarded a one-month emergency bridge order for Pluvicto and Lutathera to support cancer care at the VA Greater Los Angeles Healthcare System.
- **Government buyer:** Department of Veterans Affairs (VA), VA Greater Los Angeles Healthcare System, Network Contracting Office 22.
- **Awarded vendor and OEM:** **Novartis Pharmaceuticals Corporation**, the manufacturer of both requested radiopharmaceuticals.
- **Products:** Pluvicto and Lutathera; quantities, part numbers, and per-injection prices are not stated.
- **Purpose and requirements:** Maintain continuity of patient cancer care while the VA finalizes its longer-term FY 2027 order. The justification cites urgent patient-care needs and the medications’ specialized, proprietary nature; Novartis is identified as the only authorized source listed in the VA NAC catalog.
- **Award amount:** $769,496.80.
- **Performance period:** One-month bridge order; no option period or annual subscription is stated.

[View original listing](https://sam.gov/opp/47c029b3cf114a3ab08d08f1c44ffba3/view)